Completed NA INTERVENTIONAL 2-arm NCT01463371

Effects of Azithromycin on Airway Oxidative Stress Markers in Patients With Bronchiectasis

Effects of Long-Term Azithromycin Treatment on Airway Oxidative Stress Markers in Patients With Stable Non-Cystic Fibrosis Bronchiectasis

Sponsor: Instituto de Investigacion Sanitaria La Fe

Conditions Bronchiectasis

Interventions Azithromycin

Updated 6 times since 2017 Last updated: Sep 27, 2023 Started: Oct 31, 2006 Primary completion: Apr 30, 2007 Completion: Sep 30, 2007

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Bronchiectasis, this trial is completed. The trial is conducted by Instituto de Investigacion Sanitaria La Fe and has accumulated 6 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Oct 2023 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Oct 2023 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Oct 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Instituto de Investigacion Sanitaria La Fe
Sociedad Valenciana de Neumología

Data source: Instituto de Investigacion Sanitaria La Fe

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Valencia, Spain